Form 4 for VNRX VOLITIONRX LTD
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-18 · accession 0001477932-23-009233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-18 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.83 | +10.0K | 99.3K | +11% | +$8,300 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-18 | P | A | 10,000 | $0.83 | 99,350 | D | — | — | (F1) These shares of common stock are jointly owned by the reporting person and his spouse. |